|
Volumn 109, Issue 10, 2014, Pages 1580-1586
|
A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand
a |
Author keywords
Drug policy; legal drug market; legal highs; new psychoactive substances (NPS); New Zealand; Psychoactive Substances Act 2013
|
Indexed keywords
DESIGNER DRUG;
PIPERAZINE DERIVATIVE;
PSYCHOTROPIC AGENT;
COMMERCIAL PHENOMENA;
DRUG APPROVAL;
DRUG LEGISLATION;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
NEW ZEALAND;
SUPPLY AND DISTRIBUTION;
COMMERCE;
DESIGNER DRUGS;
DRUG APPROVAL;
HUMANS;
LEGISLATION, DRUG;
NEW ZEALAND;
PIPERAZINES;
PSYCHOTROPIC DRUGS;
|
EID: 85027932553
PISSN: None
EISSN: 13600443
Source Type: Journal
DOI: 10.1111/add.12484 Document Type: Article |
Times cited : (50)
|
References (0)
|